Compound 2370
Identifiers
- Common name: NV01
- Canonical SMILES:
CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccsc3cc2c1=O
- IUPAC name:
N-[3-(diethylamino)propyl]-2-{12-methyl-9-oxo-5-thia-1,10,11-triazatricyclo[6.4.0.0^{2,6}]dodeca-2(6),3,7,11-tetraen-10-yl}acetamide
- InChi:
InChI=1S/C18H25N5O2S/c1-4-21(5-2)9-6-8-19-17(24)12-22-18(25)15-11-16-14(7-10-26-16)23(15)13(3)20-22/h7,10-11H,4-6,8-9,12H2,1-3H3,(H,19,24)
- InChiKey:
DRDIHUMOFDGYRJ-UHFFFAOYSA-N
External links
![]() 16011141 |
![]() CHEMBL2141272 |
8C3 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
UHRF1 / H3 | 5.28 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 375.17 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 0.57 | |||
TPSA | 71.14 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1177/2472555218766278 | NV01 | UHRF1 Q96T88 |
H32 Q71DI3 |
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 4.49 | |
10.1177/2472555218766278 | NV01 | UHRF1 Q96T88 |
H32 Q71DI3 |
Biochemical assay | Isothermal Titration Calorimetry | pKd (dissociation constant, -log10) | 5.28 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4515 | 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one | DB07628 | |
0.4200 | CCX-354 | DB12963 | |
0.4120 | Avadomide | DB14857 | |
0.3954 | Trazodone | DB00656 | |
0.3872 | (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE | DB07135 | |
0.3735 | Ibrutinib | DB09053 | |
0.3674 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.3652 | (2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE | DB07092 | |
0.3608 | PRX-03140 | DB05596 | |
0.3607 | Brexpiprazole | DB09128 | |
0.3598 | Futibatinib | DB15149 | |
0.3597 | Vosaroxin | DB11999 | |
0.3594 | Rabeximod | DB05772 | |
0.3584 | AT-001 | DB15121 | |
0.3547 | Pumosetrag | DB12402 |